Drugs / Xanomeline/trospium chloride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07257120 | Jan → Jun 2026 | — | Karuna Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xanomeline/trospium chloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07257120 ↗ |